ER degradation enhancing alpha-mannosidase like protein 1
RGD ID:
1563633
Description:
Predicted to enable mannosyl-oligosaccharide 1,2-alpha-mannosidase activity and misfolded protein binding activity. Predicted to be involved in several processes, including endoplasmic reticulum mannose trimming; positive regulation of retrograde protein transport, ER to cytosol; and proteolysis involved in protein catabolic process. Predicted to act upstream of or within ERAD pathway. Predicted to be located in aggresome; endoplasmic reticulum membrane; and endoplasmic reticulum quality control compartment. Predicted to be active in endoplasmic reticulum. Orthologous to human EDEM1 (ER degradation enhancing alpha-mannosidase like protein 1); PARTICIPATES IN Endoplasmic Reticulum-associated degradation pathway; INTERACTS WITH 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine; 4,4'-diaminodiphenylmethane.
ER degradation enhancer, mannosidase alpha-like 1; ER degradation-enhancing alpha-mannosidase-like 1; ER degradation-enhancing alpha-mannosidase-like protein 1; LOC297504; RGD1563633; similar to mKIAA0212 protein
[Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of EDEM1 mRNA and [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EDEM1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EDEM1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EDEM1 mRNA
[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EDEM1 mRNA and SIRT1 protein inhibits the reaction [Cadmium Chloride results in increased expression of EDEM1 mRNA]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EDEM1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EDEM1 mRNA